The Board of Directors of NUCRYST Pharmaceuticals Corp. (Nasdaq: NCST) announced the appointment of David B. Holtz as interim President ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE